Showing results (381-390 of 525) with videos related to
Sort By:
Pageof 53
Agents and Actions. Supplements|January 1, 1992
Effect of irradiation on the prostaglandin system of human hypernephroma cellsS R Li, I Virgolini, E Wandl, et al.Wiener Klinische Wochenschrift|January 5, 1990
[Angiologic, neurologic and orthopedic findings in vibration exposed chain saw operators]T Stefenelli, D Wimberger, P Harmuth, et al.Zeitschrift Fur Gastroenterologie|February 1, 1979
[Plasmaperfusion through activated charcoal and amberlite XAD-7 in dogs with liver failure induced by yellow phosphorus (author's transl)]W Horak, P Polterauer, F Renner, et al.Revista Espanola De Medicina Nuclear|May 3, 2001
Positive imaging of an inflammatory process at an arteriovenous access site with 111 Indium-labeled plateletsI Neumann, F T Meisl, G Kopriva, et al.Breast Cancer Research and Treatment|November 10, 2000
99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesionsR Obwegeser, P Berghammer, S Muellauer-Ertl, et al.Prostaglandins|January 1, 1996
Prostaglandin E1 decreases circulating endothelial cellsH Sinzinger, P Fitscha, H Kritz, et al.Prostaglandins & Other Lipid Mediators|July 8, 1998
Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistanceH Sinzinger, I Neumann, J O'Grady, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1997
PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion techniqueH Sinzinger, I Neumann, J O'Grady, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1992
Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregationR Katzenschlager, K Weiss, W Rogatti, et al.Acta Medica Austriaca|January 1, 1985
[Hemofiltration and the neurohumoral system in patients with severe heart failure]P Wittels, K Silberbauer, D H Glogar, et al.Pageof 53